IRadimed

Winter Springs, United States Founded: 2004 • Age: 22 yrs Listed
Developer of IV Infusion system and patient monitoring systems for the MRI setting

About IRadimed

IRadimed is a publicly listed company based in Winter Springs (United States) founded in 2004. Developer of IV Infusion system and patient monitoring systems for the MRI setting. IRadimed has raised $1.5 million across 1 funding round. The company has 160 employees. IRadimed offers products and services including 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories. Its focus areas include Life Sciences, Hospital Equipment, Critical Care and Infusion Systems. Its legal entity is IRadimed Corporation. Its competitors include 410 Medical, Hospira and Ivenix; 2 of its 3 listed competitors have raised funding.

Company details

IRadimed was founded in 2004 and is headquartered in Winter Springs, United States. Medical devices for the MRI environment are developed and manufactured by the company, focusing on patient monitoring systems and IV infusion systems. FDA 510(k) clearance was obtained in 2005 for the Non-Magnetic MRidium Smart Infusion System, with additional clearance in 2009 for integration with Masimo SET SpO2 monitoring. Operations center on non-magnetic solutions for safe MRI use.

  • Headquarters Winter Springs, United States
  • Employees 160
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website iradimed.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Iradimed Corporation
Key Metrics
  • Annual Revenue
    $83.81 M (USD)
    14.43
    as on Dec 31, 2025
  • Net Profit
    $22.48 M (USD)
    16.88
    as on Dec 31, 2025
  • EBITDA
    $27.31 M (USD)
    19.89
    as on Dec 31, 2025
  • Total Equity Funding
    $1.5M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.5M (USD), Seed

    Apr 2005

  • Employee Count
    160

Products & Services of IRadimed

IRadimed offers a comprehensive portfolio of products and services, including 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories.

3880 MRI Patient Monitor
Patient Monitoring

Non-magnetic device for continuous vital sign tracking in MRI environments

3860+ MRI Infusion Pump
Infusion Systems

Non-magnetic pump for safe medication delivery during MRI procedures

FMD with Trusense
Safety Devices

Ferrous metal detector to reduce false alarms in MRI settings

MRI Clinical Accessories
Support Equipment

Accessories enhancing MRI patient care and workflow efficiency

Apps and channels of IRadimed

its YouTube channel IRadimed Corporation has 458 subscribers and 24 videos.

IRadimed Corporation
YouTube 458 subscribers 24 videos Howto & Style
Open channel

Videos from IRadimed

The most watched videos on IRadimed's YouTube channel, IRadimed Corporation (458 subscribers). Click a video to play it here.

3860+ MRidium MRI IV Infusion Pump Initial Set Up
24.9K views
ETCO2 Application Guide
20K views
IRadimed 1058 IV Set Selection
14K views
Bolus, Titrate, KVO
10.3K views

More on IRadimed Corporation.

Funding Insights of IRadimed

IRadimed has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.5 million completed in April 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.5M
  • Total Rounds 1
  • Last Round Seed β€” $1.5M
  • First Round $1.5M

    (Apr 2005)

All 1 funding rounds of IRadimed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2005$1.5MSeed––
–

People of IRadimed

23 people are tracked at IRadimed (9 in leadership, 14 in team); the tracked headcount is 160.

NameRoleGroup
Ivan Cruz
Director Of FinanceLeadership
Daniel Bennett
Vice President Of Regulatory Affairs And Quality AssuranceLeadership
Randy Waddell
Vice President Of Worldwide Sales & MarketingLeadership
Roger Susi
Founder, President, And CeoLeadership
Anthony Vuoto
DirectorLeadership
Hilda Scharen - Guivel
DirectorLeadership
Jack Glenn
Chief Financial OfficerLeadership
Kevin McCreery
Director Of Data And AnalyticsLeadership
Dain Grab
Area Sales DirectorLeadership
Brandon Snyder
Pittsburgh Area Sales ManagerTeam
Rob Mayer
Territory Sales ManagerTeam
Corey Shears
Senior Territory ManagerTeam
David Swoik
Territory Sales ManagerTeam
Jack Dawson
Territory Sales ManagerTeam
Ryan Burket
South FL Territory Sales ManagerTeam
Grant Spofford
Territory ManagerTeam
Eric Calimano
Territory ManagerTeam
Leigh Campbell
Territory Sales ManagerTeam
Brian Mehalick
Territory Sales ManagerTeam
David Lee
Software EngineerTeam

3 more people are available in the full profile.

Premium access

Complete people profiles for IRadimed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of IRadimed

IRadimed is a publicly listed company on the NASDAQ with ticker symbol IRMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date16 Jul 2014
  • Listed onNASDAQ: IRMD
  • Listed entityiRadimed Corporation
  • Exchange sectorHealth technology
  • ISINUS46266A1097
  • Share price$89.65 (+0.2% on the day) · 2026-10-13
  • Market capitalisation$1.15B
  • Price to earnings50.0
  • EPS (diluted, trailing year)$1.79
  • Dividend yield0.86%
  • Volume (last session)94,707

Financials of IRadimed

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$83.8M$22.5M$27.3M
2024$73.2M$19.2M$22.8M
2023$65.6M$17.2M$20.8M
2022$53.3M$12.8M$16.3M
2021$41.8M$9.3M$10.4M
Premium access

Detailed financial statements for IRadimed

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of IRadimed

3 dated milestones of IRadimed across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded IRadimed is founded.
  2. Funding First funding round of $1.5M.
  3. IPO Lists on the stock exchange (IPO).

Competitors of IRadimed

IRadimed has 3 listed competitors in our database, 2 of them funded. They include 410 Medical, Hospira and Ivenix.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
410medical.com2012Durham, United States$65.98M
Rapid infusion systems are provided for critically ill patients.
hospira.com2004Lake, United States2,658
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
ivenix.com2001Amesbury, United States$159.97M60
Infusion management systems are developed with wireless web-based architecture.
Premium access

Detailed competitors of IRadimed

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of IRadimed

The website of IRadimed (iradimed.com) receives about 7K visits a month.

  • Monthly visits
    7K

    ▲ 12.3% vs previous month

Similar websites

Websites whose visitors overlap most with IRadimed. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
massdevice.com
100%
#435,992View details
shields.com
89%
103.3K#291,112View details
ampliphibio.com
ampliphibio.com
61%
–
auntminnie.com
auntminnie.com
56%
#173,075–
mr-tip.com
mr-tip.com
55%
#4,484,026–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for IRadimed

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as IRadimed (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 3.07 B10,600
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Iradimed

Premium access

Complete news archive for IRadimed

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IRadimed

IRadimed was founded in 2004 and raised its 1st funding round 1 year after it was founded.

IRadimed is headquartered in Winter Springs, United States. It is registered at Winter Springs, Florida, United States.

IRadimed is a funded company, having raised a total of $1.5M across 1 funding round to date. The company's 1st funding round was a Seed of $1.5M, raised on Apr 2005.

IRadimed has 160 employees.

Annual revenue of IRadimed is $83.81M as on Dec 31, 2025.

IRadimed was founded in 2004 and is headquartered in Winter Springs, United States. Medical devices for the MRI environment are developed and manufactured by the company, focusing on patient monitoring systems and IV infusion systems. FDA 510(k) clearance was obtained in 2005 for the Non-Magnetic MRidium Smart Infusion System, with additional clearance in 2009 for integration with Masimo SET SpO2 monitoring. Operations center on non-magnetic solutions for safe MRI use.

IRadimed's top competitors include 410 Medical, Hospira and Ivenix.

IRadimed offers 3880 MRI Patient Monitor, 3860+ MRI Infusion Pump, FMD with Trusense, and MRI Clinical Accessories.

Yes, IRadimed is publicly traded on NASDAQ under the ticker symbol IRMD.

IRadimed operates through Iradimed Corporation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available